Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

Roche Basel Switzerland

China backs use of Roche’s Actemra for coronavirus

Anti-inflammatory drug will be used in patients with lung complications

- PMLiVE

Q&A: Mike Dixon

PME interviews the CEO of the Healthcare Communications Association (HCA)

HARNESSING TECHNOLOGY TO TRANSFORM HEALTHCARE IN THE DIGITAL AGE

THE IMPACT OF TECHNOLOGY IN HEALTHCARECutting-edge technology is rapidly changing the healthcare landscape. When you look closely at the rate and level of innovation brought about by tech over the...

Say Communications

- PMLiVE

Mergers and acquisitions: agents for change

Getting the best from your agency in a disruptive time

Bedrock Healthcare Communications

Keeping calm and carrying on: COVID-19 and approaches to CME/CPD during a viral outbreak

Celeste Kolanko, Managing Director, Liberum OPEN Health

OPEN Health

- PMLiVE

Alnylam scores EU approval for RNAi drug Givlaari

Company says it will work towards value-based agreements for the drug

- PMLiVE

BMS partners with Voluntis to co-develop oncology digital therapeutics

Aims to create a mobile app to help patients self-manage their symptoms

- PMLiVE

AbbVie says Allergan takeover delayed by FTC verdict

Merger now likely to complete in second quarter rather than first

- PMLiVE

Promoting enthusiasm and scientific expertise at Porterhouse Medical

Porterhouse Medical Group is delighted to announce that Beth Wynne-Evans has been promoted to Senior Medical Writer.Beth makes an important and vibrant contribution to our scientific services solutions at Porterhouse....

Porterhouse Medical Group

- PMLiVE

India’s export curbs raise fears of global drug shortages

Decision comes amid increased concerns over coronavirus outbreak

- PMLiVE

Putting commercial intelligence at the heart of strategy

Keys to gaining a competitive advantage and achieving success

Top 10 Most Important Advisor Questions

Impetus Digital shares its Top 10 list of the most important advisor questions.

Impetus Digital

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links